Unique Molecular Signatures of Alzheimer's Disease Amyloid β Peptide Mutations and Deletion During Aggregate/Oligomer/Fibril Formation

被引:7
|
作者
Poduslo, Joseph F.
Howell, Kyle G.
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN USA
[2] Mayo Clin, Dept Neurosci, Rochester, MN USA
[3] Mayo Clin, Dept Biochem Mol Biol, Rochester, MN USA
关键词
protein aggregation; protein oligomers; amyloid fibrils; HEREDITARY CEREBRAL-HEMORRHAGE; DUTCH TYPE; IN-VIVO; AGGREGATION; OLIGOMERS; GENE;
D O I
10.1002/jnr.23507
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The formation of amyloid (A) peptide aggregates, oligomers, and fibrils is a dynamic process; however, the kinetics of their formation is not well understood. This study compares the time course of aggregate/fibril formation by transmission electron microscopy (TEM) analyses with that of oligomer/fibril formation by Western blot analysis under native and denaturing conditions. Efforts to deaggregate/defibrillate these peptides by using hexafluoroisopropanol, ammonium hydroxide, or dimethylsulfoxide did not change the nondenaturing polyacrylamide gel electrophoresis (PAGE) footprints or drive the peptides to a monomeric species. Regardless of the pretreatment protocol, TEM analyses reveal that all A peptides (A40, A42, A39E22 [Osaka], A40E22G [Arctic], A40E22Q [Dutch], and A40A2T [Icelandic]) immediately formed nonfibrillar, amorphous aggregates when first placed into solution with the Osaka mutation, quickly forming early-stage fibrils. The extent of fibril formation for other A peptides is time dependent, with the Arctic mutation forming fibrils at 1 hr, the Dutch and Icelandic at 4 hr, A42 at 8 hr, and A40 at 24 hr. In contrast, nondenaturing PAGE revealed unique footprints for the different A species. The rapidity of aggregate formation and the rapid transition to fibrils, particularly for the Osaka deletion, suggest an important role for aggregates/fibrils of A in the development of neuronal degeneration. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:410 / 423
页数:14
相关论文
共 50 条
  • [1] A molecular model of Alzheimer amyloid β-peptide fibril formation
    Tjernberg, LO
    Callaway, DJE
    Tjernberg, A
    Hahne, S
    Lilliehöök, C
    Terenius, L
    Thyberg, J
    Nordstedt, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) : 12619 - 12625
  • [2] Molecular mechanisms initiating amyloid β-fibril formation in Alzheimer's disease
    Kirkitadze, MD
    Kowalska, A
    ACTA BIOCHIMICA POLONICA, 2005, 52 (02) : 417 - 423
  • [4] Modulation of β-Amyloid Fibril Formation in Alzheimer's Disease by Microglia and Infection
    Brown, Madeleine R.
    Radford, Sheena E.
    Hewitt, Eric W.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [5] Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-β peptide
    Cottingham, MG
    Hollinshead, MS
    Vaux, DJT
    BIOCHEMISTRY, 2002, 41 (46) : 13539 - 13547
  • [6] A carboxylated Zn-phthalocyanine inhibits fibril formation of Alzheimer's amyloid β peptide
    Tabassum, Shatera
    Sheikh, Abdullah M.
    Yano, Shozo
    Ikeue, Takafumi
    Handa, Makoto
    Nagai, Atsushi
    FEBS JOURNAL, 2015, 282 (03) : 463 - 476
  • [7] Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease
    Drolle, Elizabeth
    Hane, Francis
    Lee, Brenda
    Leonenko, Zoya
    DRUG METABOLISM REVIEWS, 2014, 46 (02) : 207 - 223
  • [8] Polymorphic fibril formation by residues 10-40 of the Alzheimer's β-amyloid peptide
    Paravastu, Anant K.
    Petkova, Aneta T.
    Tycko, Robert
    BIOPHYSICAL JOURNAL, 2006, 90 (12) : 4618 - 4629
  • [9] The role of lipid membrane in amyloid fibril formation and toxicity in Alzheimer's disease
    Drolle, E.
    Hane, F.
    Choi, Y.
    Attwood, S.
    Ollagnier, A.
    Finot, E.
    Leonenko, Z.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2013, 42 : S120 - S120
  • [10] Characterization of a Novel Mouse Model of Alzheimer's Disease-Amyloid Pathology and Unique β-Amyloid Oligomer Profile
    Liu, Peng
    Paulson, Jennifer B.
    Forster, Colleen L.
    Shapiro, Samantha L.
    Ashe, Karen H.
    Zahs, Kathleen R.
    PLOS ONE, 2015, 10 (05):